Minifibro 25mg Tablet

This page serves as your comprehensive resource for Minifibro 25mg Tablet. We delve into the specifics of this medication, including its indications, the precise way it should be administered, a detailed account of possible side effects, and crucial information regarding contraindications and precautions. Enhance your understanding of Minifibro 25mg Tablet and its role in your treatment plan.

MRP: ₹
Packing:
Salt Combination: Mifepristone (25mg)
Brand: Akumentis Healthcare Ltd
Uses: Medical abortion

Description

Minifibro 25mg Tablet is an anti-progestational steroid class of drug used for medical termination of pregnancy
It works by blocking the action of progesterone, an essential hormone for the development of pregnancy
Minifibro 25mg Tablet is given alone or in combination with some other medicine to attain the maximum benefit
It should be taken with food or as your doctor's advice
It should be taken orally, by swallow the tablets whole with a glass of water
If you experience vomiting within 45 minutes of tablet intake, inform your doctor or take another tablet
The medicine may take 24- 48 hours to show its action and you experience bleeding.
The most common side effects of this medicine include nausea, vomiting, uterine cramps, diarrhea, infection following abortion, and uterine bleeding
If these bother you or appear serious, let your doctor know
There may be ways of reducing or preventing them
If you experience heavy vaginal bleeding or abdominal pain on taking this medicine, you should inform your doctor immediately.
Before taking this medicine, tell your doctor if you have ever had an ectopic pregnancy, or you are breastfeeding or using an intrauterine device
Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works
You must avoid strenuous activity like heavy exercise, running, and driving while abortion as it can affect the bleeding
Your doctor may perform an ultrasound or pelvic examination to check for abortion completion.

Cautions

Liver:	CONSULT YOUR DOCTOR: There is limited information available on the use of Minifibro 25mg Tablet in patients with liver disease. Please consult your doctor.
Kidney:	CONSULT YOUR DOCTOR: There is limited information available on the use of Minifibro 25mg Tablet in patients with kidney disease. Please consult your doctor.
Driving:	UNSAFE: Minifibro 25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Breast feeding:	CONSULT YOUR DOCTOR: Minifibro 25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency:	UNSAFE: Minifibro 25mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Alcohol:	UNSAFE: It is unsafe to consume alcohol with Minifibro 25mg Tablet.
Drug Action:	Antiprogestins
Therapeutic class:	GYNAECOLOGICAL
Habit Forming:	No
Chemical Class:	Oxosteroid